FetalEase

Company Overview

Snapshot

Founded in November 2016 by Aaron Feldman, FetalEase operates with 1–10 employees. The company has completed one funding round, focusing on medical device innovation. In January 2025, FetalEase secured SAFE funding, highlighting ongoing development in its core technology.

Business overview

FetalEase develops medical devices for obstetric care, specifically addressing shoulder dystocia during childbirth. Its core product, the Yaari Extractor, is a mechanical solution designed to assist physicians in resolving difficult births. The device uses control arms and a flexible engagement element to manipulate the fetal shoulder, facilitating safer delivery. FetalEase operates within the Health Tech & Life Sciences sector, serving the healthcare industry and providers with specialized medical treatment and therapeutics.

Strategic signal

In September 2023, FetalEase's Yaari Extractor was highlighted as the first-ever device specifically designed for releasing a baby's stuck shoulder at birth. This recognition underscores the company's innovative approach to a critical obstetric challenge, signaling its potential to significantly improve birth outcomes and establish a new standard of care in medical treatment and therapeutics.

Company Intelligence Q&A

What is FetalEase's primary product?

FetalEase's primary product is the Yaari Extractor, a mechanical device designed to aid physicians in resolving shoulder dystocia during childbirth by manipulating the fetal shoulder for safer delivery.

When was FetalEase founded?

FetalEase was founded in November 2016.

What significant funding event did FetalEase complete recently?

In January 2025, FetalEase secured SAFE funding to support its ongoing development in medical device technology.

Who is a co-founder of FetalEase?

Aaron Feldman is a co-founder and CEO of FetalEase.

What is the employee count for FetalEase?

FetalEase currently has 1–10 employees.